Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
Fifteen samples of non-tumoural breast tissue, 24 cases of benign lesions, four biopsies of inflammatory carcinomas and 94 tumour samples of primitive mammary carcinomas were analysed for HLA class II expression. We found, first, that HLA class II antigens were detectable in all cases of non-neoplastic breast tissue. Secondly, HLA class II antigen expression was notably increased in benign neoplasms and hyperplastic lesions. In contrast, only 32 out of 94 carcinomas showed expression of HLA-DR antigens, 17 tumours had HLA-DP antigens and 11 carcinomas were positive for the presence of DQ molecules. The expression of class II antigen was associated with the degree of histological differentiation (P < 0.05) but was independent of stromal leucocytic infiltration. Thirdly, HLA-DR was very strongly expressed in intravascular tumoural thrombi, especially in the 'inflammatory carcinomas'. The immunophenotype of inflammatory infiltrate was analysed in benign and malignant lesions. In malignant lesions the mean number of inflammatory cells was significantly higher than in benign lesions. Interestingly, we found no differences in the amount and composition of inflammatory infiltrate between HLA-DR positive and negative tumours.
D000230:Adenocarcinoma / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D015703:Antigens, CD / Q000032:analysis; D000951:Antigens, Neoplasm / Q000096:biosynthesis*; D001940:Breast / Q000276:immunology* / Q000378:metabolism; D001941:Breast Diseases / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D002277:Carcinoma / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D018275:Carcinoma, Lobular / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation; D004848:Epithelium / Q000378:metabolism; D005260:Female; D005348:Fibrocystic Breast Disease / Q000378:metabolism / Q000473:pathology; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006801:Humans; D016130:Immunophenotyping
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D006684:HLA-DR Antigens